We are also treating neuroblastoma
cells in the laboratory with combinations of new targeted treatments that exploit the genetic mistakes in neuroblastoma
, so protecting the normal cells of the body and avoiding side effects of chemotherapy and radiotherapy.
Sometimes, there are deposits of neuroblastoma
in the skin, which appear as small, blue-colored lumps.
Conclusion: Micro ribonucleic acid 34-a might suppress the progression of neuroblastoma
through inhibiting the expression of the potential target gene CD44.
can be resistant to traditional therapy, and survival can be poor.
is an orphan oncology condition with significant unmet medical need.
We are not too sure if it's starting to show signs of neuroblastoma
The researchers found that, despite some improvements in treatment over the last 10-20 years, survival for children with relapsed, high risk neuroblastoma
remains very low.
Radiographic imaging results were consistent with metastatic neuroblastoma
originating in the right adrenal medulla with metastasis to the bone marrow.
We retrieved 36 cases of Olfactory neuroblastoma
from the surgical pathology database of Section of Histopathology, Aga Khan University Hospital reported between January 1993 and December 2014 through "Integrated Laboratory Management System (ILMS)" software.
The report reviews pipeline therapeutics for Neuroblastoma
by companies and universities/research institutes based on information derived from company and industry-specific sources
is an embryonic malignancy arising from the neuroblasts which show tremendous clinical heterogeneity.
And the protocol developed by Park and her colleagues in the Children's Oncology Group has been adopted as the new standard of care for kids with neuroblastoma
across North America.